Skip to content

ISOperistaltic Versus ANTIperistaltic Anastomosis After Laparoscopic Right Colectomy for Cancer

Randomized Clinical Trial Comparing Isoperistaltic Versus Antiperistaltic Side to Side Anastomosis After Right Laparoscopic Hemicolectomy for Cancer.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02309931
Acronym
ISOVANTI
Enrollment
108
Registered
2014-12-05
Start date
2014-06-30
Completion date
2017-11-01
Last updated
2023-03-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary Malignant Neoplasm of Ascending Colon

Keywords

Right hemicolectomy, Side-to-side anastomosis, Orocecal time, Antipersitaltic, Isoperistaltic, Laparoscopic colectomy, Right laparoscopic hemicolectomy

Brief summary

The study will provide a precise control compared to the two interventions (iso vs antiperistaltic anastomoses) with thorough measurements of the postoperative variables and complications to improve the evaluation of the surgical technique. It will also enable an evaluation of the quality of life after the procedures.

Interventions

PROCEDUREantiperistaltic side-to-side ileocecal anastomosis

Right laparoscopic hemicolectomy + antiperistaltic side-to-side ileocecal anastomosis

PROCEDUREisoperistaltic side-to-side ileocecal anastomosis

Right laparoscopic hemicolectomy+isoperistaltic side-to-side ileocecal anastomosis

Sponsors

Hospital Universitario Virgen de la Arrixaca
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Caregiver)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* The patient has given informed consent to participate * No surgery contraindications * Elective surgery * No pregnancy or nursery during the study * Older than 18 years * Complete preoperative cancer staging * Tumour characteristics: * Cecum, ascending, hepatic angle or transverse colon tumour confirmed by endoscopic biopsy * Radiologically resectable tumours * Absence of vascular, nervous or bone infiltration * T4 stages with near organ infiltration * Absence of peritoneal carcinomatosis * Absence of respiratory pathology that prevents for doing hydrogen breath test

Exclusion criteria

* Pregnancy * Intestinal bowel disease like Crohn's disease or ulcerative colitis. * Metastatic bone illness * Previous abdominal surgery with bowel resection * Malabsorption syndromes

Design outcomes

Primary

MeasureTime frameDescription
postoperative complicationswithin the first 30 days up to one year after surgeryNumber of patients with postoperative complications and grade of Clavien-Dindo

Secondary

MeasureTime frameDescription
Anastomosis timeFrom the enteromy to its closure.
Hospital length of sayparticipants will be followed for the duration of hospital stay, an expected average of 4 days
first tolerance dayparticipants will be followed for the duration of hospital stay, an expected average of 4 daysFirst day taking liquids without vomits or abdominal distension
Operating timeDuring surgery
first faeces dayparticipants will be followed for the duration of hospital stay, an expected average of 4 days
Orocecal transitup to one yearUsing hydrogen breath test curves. preoperative, at day 2 postoperative, 1 month, 6 months and 1 year.
Gastrointestinal life qualityup to one yearUsing gastrointestinal quality life index questionnaire. preoperative, 1 month, 6 months and 1 year.
first flatus dayparticipants will be followed for the duration of hospital stay, an expected average of 4 days

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 9, 2026